Prospective Evaluation of 68-Ga-PSMA -PET and Early PSA Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PROPER
- 27 Jun 2017 Planned End Date changed from 1 Mar 2027 to 1 Dec 2017.
- 27 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated